These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34341035)

  • 21. Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management.
    Somma V; Ha FJ; Palmer S; Mohamed U; Agarwal S
    Heart Rhythm; 2023 Feb; 20(2):282-290. PubMed ID: 36356656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapidly progressive heart failure after dual-chamber pacemaker implantation.
    Seydoux C; Suter P; Graf D; Vivekanantham H
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34645631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of cardiac resynchronisation therapy in patients with wide QRS and non-specific intraventricular conduction delay: rationale and design of the multicentre randomised NICD-CRT study.
    Eschalier R; Ploux S; Pereira B; Clémenty N; Da Costa A; Defaye P; Garrigue S; Gourraud JB; Gras D; Guy-Moyat B; Leclercq C; Mondoly P; Bordachar P
    BMJ Open; 2016 Nov; 6(11):e012383. PubMed ID: 27836874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of pacing-induced cardiomyopathy in pacemaker-dependent patients is lower with leadless pacemakers compared to transvenous pacemakers.
    Sanchez R; Nadkarni A; Buck B; Daoud G; Koppert T; Okabe T; Houmsse M; Weiss R; Augostini R; Hummel JD; Kalbfleisch S; Daoud EG; Afzal MR
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):477-483. PubMed ID: 33205561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors of pacing-induced cardiomyopathy.
    Zhang H; Zhou YJ; Zeng YJ
    Chin Med J (Engl); 2020 Jul; 133(13):1533-1539. PubMed ID: 32568868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic benefit of upgrade to cardiac resynchronization therapy in patients with pacing-induced cardiomyopathy.
    Kerley RN; O'Dowling C; Campos F; Murphy RD; Walsh KA; Fahy GJ
    Heart Rhythm O2; 2023 Apr; 4(4):225-231. PubMed ID: 37124556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and predictors of right ventricular pacing-induced cardiomyopathy.
    Khurshid S; Epstein AE; Verdino RJ; Lin D; Goldberg LR; Marchlinski FE; Frankel DS
    Heart Rhythm; 2014 Sep; 11(9):1619-25. PubMed ID: 24893122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronization therapy is appropriate for all patients requiring chronic right ventricular pacing: the pro perspective.
    Herweg B; Singh R; Barold SS
    Card Electrophysiol Clin; 2015 Sep; 7(3):433-44. PubMed ID: 26304523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central Sleep Apnea and Pacing-Induced Cardiomyopathy.
    Barbieri F; Adukauskaite A; Heidbreder A; Brandauer E; Bergmann M; Stefani A; Holzknecht E; Senoner T; Rubatscher A; Schgör W; Stühlinger M; Pfeifer BE; Bauer A; Hintringer F; Högl B; Dichtl W
    Am J Cardiol; 2021 Jan; 139():97-104. PubMed ID: 33002463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. His-bundle pacing: A novel treatment for left bundle branch block-mediated cardiomyopathy.
    Singh R; Devabhaktuni S; Ezzeddine F; Simon J; Khaira K; Dandamudi G
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2730-2736. PubMed ID: 32713017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features, predictors, and long-term prognosis of pacing-induced cardiomyopathy.
    Cho SW; Gwag HB; Hwang JK; Chun KJ; Park KM; On YK; Kim JS; Park SJ
    Eur J Heart Fail; 2019 May; 21(5):643-651. PubMed ID: 30734436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy.
    Singh JP; Solomon SD; Fradley MG; Barac A; Kremer KA; Beck CA; Brown MW; McNitt S; Schleede S; Zareba W; Goldenberg I; Kutyifa V;
    JAMA; 2019 Nov; 322(18):1799-1805. PubMed ID: 31714987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Resynchronization Therapy in Patients With Nonischemic Cardiomyopathy Using Left Bundle Branch Pacing.
    Huang W; Wu S; Vijayaraman P; Su L; Chen X; Cai B; Zou J; Lan R; Fu G; Mao G; Ellenbogen KA; Whinnett ZI; Tung R
    JACC Clin Electrophysiol; 2020 Jul; 6(7):849-858. PubMed ID: 32703568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. His bundle pacing for cardiac resynchronization therapy: a systematic literature review and meta-analysis.
    Qi J; Jia X; Wang Z
    J Interv Card Electrophysiol; 2020 Nov; 59(2):463-470. PubMed ID: 32748157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: A crossover design comparison.
    Lustgarten DL; Crespo EM; Arkhipova-Jenkins I; Lobel R; Winget J; Koehler J; Liberman E; Sheldon T
    Heart Rhythm; 2015 Jul; 12(7):1548-57. PubMed ID: 25828601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival of patients with pacing-induced cardiomyopathy upgraded to CRT does not depend on defibrillation therapy.
    Loboda D; Gibinski M; Zietek K; Wilczek J; Gardas R; Gladysz-Wanha S; Golba KS
    Pacing Clin Electrophysiol; 2020 May; 43(5):471-478. PubMed ID: 32198771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
    Tawfik Ghanem M; Allam LE; Samir Ahmed R
    Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of left bundle branch area pacing compared with biventricular pacing in patients with heart failure: A matched case-control study.
    Wang Y; Gu K; Qian Z; Hou X; Chen X; Qiu Y; Jiang Z; Zhang X; Wu H; Chen M; Zou J
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2068-2077. PubMed ID: 32562442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION Trial.
    Bristow MR; Saxon LA; Feldman AM; Mei C; Anderson SA; DeMets DL
    JACC Heart Fail; 2016 Jul; 4(7):521-535. PubMed ID: 27289408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.